| Literature DB >> 29472755 |
Graham R Cumming1, Tao Zhang2, Gaia Scalabrino2, Neil Frankish2,3, Helen Sheridan2,3.
Abstract
PH46A, belonging to a class of 1,2-Indane dimers, has been developed by our research group as a potential therapeutic agent for the treatment of inflammatory and autoimmune diseases. The initial synthetic route to PH46A gave a low overall yield, due in large part to the generation of undesired diastereoisomer 5 and the unwanted enantiomer (R,R)-8 during the synthesis. The aim of this work was to carry out a comprehensive investigation into the stereoselective synthesis of PH46A. Significant progress was made on the ketone reduction step, where the use of triisobutylaluminum [TiBA, Al(iBu)3] afforded high selectivity for the target diastereoisomer (rac)-6, compared to the unfavorable ratio obtained using a previous process. This enabled a multikilo scale synthesis of PH46A in a GMP environment. Further, a brief proof-of-principle investigation was carried out using an achiral phase transfer catalyst (PTC) for alkylation at the methine carbon of the parent indanone.Entities:
Year: 2017 PMID: 29472755 PMCID: PMC5814955 DOI: 10.1021/acs.oprd.7b00258
Source DB: PubMed Journal: Org Process Res Dev ISSN: 1083-6160 Impact factor: 3.317
Scheme 1(a) Original Synthetic Route to PH46A with Key Intermediates Generated from Steps 3 and 5; (b) Proposed Stereoselective Synthesis of the Desired Isomer (S,S)-6
Scheme 2Reduction of Ketone 4
Reductions of Ketone 4 Using NaBH4 in IPAa
| D1/D2 ratio (area% conversion) | ||||
|---|---|---|---|---|
| entry | conditions | 16 h/rt | +4 h/50 °C | +28 h/50 °C |
| 1A | 0.25 equiv of NaBH4 | 50:50 (2%) | 50:50 (10%) | 47:53 (47%) |
| 1B | 0.5 equiv of NaBH4 | 48:52 (3%) | 49:51 (17%) | 42:58 (95%) |
| 1C | 1.0 equiv of NaBH4 | 46:54 (3%) | 48:52 (34%) | 42:58 (>99%) |
| 1D | 2.0 equiv of NaBH4 | 44:55 (6%) | 48:52 (62%) | 31:69 (>99%) |
Conditions: IPA (100 mL/g).
Ratios measured from Me-ester peaks by HPLC.
Ratios measured from iPr-ester peaks by HPLC.
Accompanied by significant hydrolysis to 7 and 8 and other byproducts.
Reductions of Ketone 4 Using NaBH4 and LiBH4 in Diglymea
| D1/D2 ratio (area% conversion) | ||||
|---|---|---|---|---|
| entry | conditions | 3 h/rt | overnight/rt | +8 h/90 °C |
| 2A | 1 equiv of NaBH4 | 58:42 (8%) | 56:44 (12%) | 46:54 (85%) |
| 2B | 1 equiv of NaBH4/TEA | 60:40 (5%) | 56:44 (6%) | 48:52 (>99%) |
| 2C | 0.25 equiv of LiBH4 | 63:37 (18%) | 60:40 (31%) | 54:46 (92%) |
| 2D | 0.5 equiv of LiBH4 | 61:39 (23%) | 58:42 (49%) | 50:50 (97%) |
| 2E | 1.0 equiv of LiBH4 | 60:40 (33%) | 56:44 (79%) | 51:49 (>99%) |
Conditions: Diglyme (100 mL/g).
Ratios measured from Me-ester peaks by HPLC.
Reduced accuracy due to byproduct formation.
Reductions of Ketone 4 Using Al(OiPr)3 (Entries 3–6) and MPVO-Scrambling of Mixture 5/6 Using Nd(OiPr)3 (Entry 7)a
| D1/D2 ratio
(area% conversion) | |||||
|---|---|---|---|---|---|
| entry | conditions | 2 h | 5.5 h | 16 h | 22 h |
| 3A | 2 equiv of Al(O | n.r. | n.r. | n.r. | n.r. |
| 3B | 2 equiv of Al(O | – | – | 5:95 (28%) | n.c. |
| 3C | 2 equiv of Al(O | – | – | 6:94 (7%) | n.c. |
| 3D | 2 equiv of Al(O | (<2%) | – | – | n.c. |
| 4A | 2 equiv of Al(O | 5:95 (21%) | 5:95 (47%) | – | 5:95 (84%) |
| 4B | 4 equiv of
Al(O | 5:95 (44%) | 5:95 (76%) | – | 6:94 (90%) |
| 4C | 0.2 equiv of
Nd(O | 20:80 (<2%) | 20:80 (2%) | – | (12%) |
| 5 | 2 equiv of Al(O | 12:88 (26%) | 13:87 (42%) | – | 23:77 (53%) |
| 6A | 4 equiv of Al(O | – | – | – | 20:80 (75%) |
| 6B | 4 equiv of
Al(O | – | – | – | 11:89 (87%) |
| 6C | 4 equiv of Al(O | – | – | – | 5:95 (83%) |
| 7 | Nd(O | 89:11 | – | – | – |
Conditions: see table.
Ratio measured from Me ester peaks at low conversion.
Ratio measured from iPr-ester peaks at low conversion; TOL = toluene; n.r. = no reaction; n.c. = no change; (−) = not determined. Scale: 1 mmol ketone 4 except for entry 5 (10 mmol).
Scheme 3MPVO Scrambling of Diastereoisomer Mixture 5/6 Using a Neodymium(III) Catalyst
Reductions of Ketone 4 Using Al(iBu)3a
| D1/D2 ratio | |||
|---|---|---|---|
| entry | conditions | 2 h | +72 h |
| 8A | 1 equiv of Al( | 8:92 (>99%) | n.a. |
| 8B | 1 equiv of Al( | 6:94 (92%) | n.c. |
| 8C | 1 equiv of Al( | 7:93 (97%) | 13:87 (25%) |
| 8D | 2 equiv of Al( | 11:89 (>99%) | n.c. |
| 9A | 1 equiv of Al( | 13:87 (>99%) | n.c. |
| 9B | 1 equiv of Al( | <1% | n.a. |
| 10A | 1 equiv of Al( | 6:94 (>99%) | n.a. |
| 10B | 1 equiv of Al( | 7:93 (>99%) | n.a. |
| 10C | 1 equiv of Al( | 7:93 (>99%) | n.a. |
| 10D | 1 equiv of Al( | 7:93 (>99%) | n.a. |
Conditions: see table.
Ratio measured from Me ester peaks; TOL = toluene; n.a. = not applicable (reaction quenched at 2 h); n.c. = no change. Scale: 1 mmol ketone 4 except for entry 10 C (0.5 mmol) and entry 10D (20 mmol).
Scheme 4Reduction of Ketone 4 Using TiBA on 100 g Scale
Figure 1Molecular structures of keto tBu-ester 12 and the unsaturated ketone 13.
Figure 21H NMR spectrum of hydroxyl Me-ester 6.